Affiliation:
1. Kabardino-Balkar state University after H. M. Berbekov
2. Republican clinical hospital after Sh. Sh. Ependiev
Abstract
BACKGROUND. Among the causes of death in patients with chronic kidney disease (CKD) on dialysis, cardiovascular complications play a leading role. One of them is acute incidences of cerebral circulation (AICC). The assessment of the impact of mineral and bone disorders on the risk of developing AICC is interesting and on par with the assessment of the impact of traditional risk factors. THE AIM: to evaluate the effects of bone mineral disorders on the risk of acute cerebrovascular accident in patients with stage 5 D CKD. PATIENTS AND METHODS. A single-center cohort prospective (three-year) study of 85 patients with stage 5D CKD on program hemodialysis was conducted. In the first stage, we evaluated traditional risk factors (blood pressure, echocardiography parameters) and parameters that reflect bone mineral disorders (parathyroid hormone, blood phosphate, calcium levels, 1.25 (OH) D, fibroblast growth factor-FGF-23, a-klotho of blood). Signs of calcification of the heart valves (CHV) and the aortic wall (CAW) were also recorded. In the second stage, three years later, patients were re-examined with the registration of the endpoint, which was identified as cases of fatal and non-fatal AICC. RESULTS. Within three years, 10 cases of AICC were registered. Mineral and bone disorders in patients on hemodialysis, such as hyperphosphatemia, CKD and its severity are risk factors for the development of AICC. It is shown that the severity of CCS and pulse pressure levels determined before the dialysis procedure and intradialytic have a positive effect on the risk of AICC. Factors such as FGF-23 and α-Klotho of blood have not demonstrated their effect on the risk of AICC.
Publisher
Non-profit organization Nephrology
Reference13 articles.
1. Saran R., Li Y., Robinson B. et al. US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis2016; 67 (3): 1–305
2. Tonelli M., Karumanchi S. A., Thadhani R. et al. Epidemiology and mechanisms of uremia-related cardiovascular disease. Circulation 2016; 133 (5): 518–536
3. Ulusoy S., Ozkan G., Guvercin B., Yavuz A. The Relation Between Variability of Intact Parathyroid Hormone, Calcium, and Cardiac Mortality in Hemodialysis Patients. Artificial Organs 2016; 40 (11): 1078–1085
4. Li D., Zhang L., Zuo L. et al. Association of CKD-MBD Markers with All-Cause Mortality in Prevalent Hemodialysis Patients: A Cohort Study in Beijing. PLoS ONE 2017; 12 (1): 0168537
5. Milovanova L. Yu. Vzaimosvyaz' faktora rosta fibroblastov-23 (FGF-23) SKLOTHO, troponina-I u bol'nykh khronicheskoi bolezn'yu pochek / L. Yu. Milovanova [i dr.] // Mezhdunarodnyi nauchno-issledovatel'skii zhurnal. – 2016. – 51 (9-13): 65–68. doi: 10.18454/IRJ.2016.51.074 / Milovanova L. Yu., Kozlovskaya L. V., Milovanova S. Yu. etc. Relation-ship of fibroblast growth factor-23 (FGF-23) KLOTHO, troponin-I in patients with chronic kidney disease. International Research Journal 2016; 51 (9-13): 65–68